BoTeng Biology and Hualong Biology reached a strategic cooperation to accelerate the development of MATC cell drugs.

Suzhou Bote Bioscience Co., Ltd. announced a strategic cooperation with Innovativetherapy research and development company Henan Hualong Biotechnology Co., Ltd. According to the agreement, Bote Bioscience will provide one-stop services for Hualong Biotechnology from process optimization to registration declaration for MATC therapy, to accelerate the development of MATC cell therapy.